Guardant Health
GH
#2556
Rank
โ‚น428.13 B
Marketcap
โ‚น3,469
Share price
-3.43%
Change (1 day)
128.95%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚น428.13 Billion

As of April 2025 Guardant Health has a market cap of โ‚น428.13 Billion. This makes Guardant Health the world's 2556th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น428.13 B32.69%
2024โ‚น322.64 B18.04%
2023โ‚น273.33 B18.55%
2022โ‚น230.56 B-69.53%
2021โ‚น756.79 B-19.69%
2020โ‚น942.29 B80.08%
2019โ‚น523.26 B132.16%
2018โ‚น225.39 B

End of Day market cap according to different sources

On Apr 4th, 2025 the market cap of Guardant Health was reported to be:

โ‚น428.13 Billion
by Nasdaq info icon info icon
โ‚น428.13 Billion
by CompaniesMarketCap info icon info icon
โ‚น428.13 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น1.546 T 261.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น144.64 B-66.21%๐Ÿ‡บ๐Ÿ‡ธ USA